CMSH China Medical

 

TIDMCMSH 
 
RNS Number : 4453F 
China Medical Systems Holdings Ltd 
13 January 2010 
 
+------------------------------------------+------------------------------------------+ 
| For immediate release                    |                          13 January 2010 | 
+------------------------------------------+------------------------------------------+ 
 
 
not for release, publication or distribution, directly or indirectly, in whole 
or in part, in, into or from the United States of America, Australia, Canada or 
Japan or any other jurisdiction where to do so might constitute a violation of 
the relevant laws or regulations of such jurisdiction. 
 
 
China Medical System Holdings Limited 
 
 
("CMS" or "the Company") 
 
 
Trading Update 
 
 
China Medical System Holdings Ltd. (AIM: CMSH), a leading pharmaceutical 
contract sales & marketing company in China, is pleased to provide shareholders 
with a trading update. The Company expects to release its annual results for the 
year ended 31 December 2009 before the end of April 2010. 
The Company is pleased to report that unaudited sales for the year ended 31 
December 2009 are expected to be approximately US$96million which represents a 
year over year growth of approximately 32%; up from US$73 million for the year 
ended 31 December 2008. 
Commenting on the update, Mr. Lam Kong, CEO of the Company said: "2009 was 
another year of great achievement for CMS which demonstrated the successful 
execution of our growth strategy, namely, to in-license, on an exclusive basis, 
high quality pharmaceuticals with significant market potential and expand the 
sales network to further enhance our core competence and market share. 
 
 
While maintaining strong growth of our existing products, we intend to introduce 
no less than 2 additional imported products in 2010 to further diversify our 
product portfolio and expand our therapeutic focus. Currently, we are having 
discussions with prospective suppliers who are interested in licensing out their 
products to CMS. Aside from the traditional exclusive agency approach, we are 
also exploring other internationally accepted practices to in-license products 
from overseas suppliers, thereby offering greater flexibility in our 
co-operation with business partners. 
 
 
In 2010, we plan to further expand our sales network. We have recently launched 
an internship program aiming at adding about 300 medical graduates or post 
graduates, some of whom will be selected to be front line salespersons after 
completing our rigorous training programs. 
 
 
CMS is a well-established company and given the local Chinese markets it 
operates in, we believe it is now appropriate to explore the potential listing 
of the Company's shares on the Stock Exchange of Hong Kong Limited. It is the 
current intention that the proposed listing will be in addition to the Company's 
current AIM listing." 
 
 
As the success of the proposed additional listing is subject to the fulfillment 
of a number of conditions, including but not limited to the listing approval 
from The Stock Exchange of Hong Kong Limited as well as the market conditions, 
the proposed additional listing may or may not proceed. Shareholders of the 
Company and potential investors should exercise caution when dealing in the 
shares of the Company. 
 
 
For further information, please contact: 
+----------------------------------------------+---------------------------------+ 
|                       China Medical System   |                               + | 
|                       Holdings Ltd           |                           (852) | 
|                                              |                            2369 | 
|                                              |                            3889 | 
+----------------------------------------------+---------------------------------+ 
| Vincent Hui                                  |                                 | 
+----------------------------------------------+---------------------------------+ 
|                       Seymour Pierce Limited |                               + | 
|                                              |                              44 | 
|                                              |                          (0) 20 | 
|                                              |                       7107 8344 | 
+----------------------------------------------+---------------------------------+ 
|                       Chris Howard /         |                                 | 
|                       Huaizheng Peng         |                                 | 
+----------------------------------------------+---------------------------------+ 
 
 
The information contained in this document is not for release, publication or 
distribution, directly or indirectly, in whole or in part, in, into or from in 
the United States of America (including its territories and possessions, any 
state of the United States and the District of Columbia). These materials do not 
contain, constitute or form part of an offer to sell or the solicitation of an 
offer to purchase securities in the United States. The securities referred to 
herein (the "Securities") have not been and will not be registered under the US 
Securities Act of 1933, as amended (the "Securities Act"), and may not be 
offered or sold in the United States absent registration under the Securities 
Act except pursuant to an available exemption from, or in a transaction not 
subject to, the registration requirements of the Securities Act. There will be 
no public offer of the Securities in the United States. 
 
 
Notes for editors 
 
 
China Medical System Holdings Limited 
China Medical System Holdings Limited (CMS) is listed on AIM of the London Stock 
Exchange with the ticker symbol "CMSH". It is an integrated and profitable 
pharmaceutical company, which manufactures, sells and markets prescription drugs 
in China. For further information, please visit www.chinamedicalsystem.com 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 TSTKKBDKOBKDQDD 
 

Grafico Azioni China Medical (LSE:CMSH)
Storico
Da Mag 2024 a Giu 2024

Grafico Azioni China Medical (LSE:CMSH)
Storico
Da Giu 2023 a Giu 2024